Dr. David Martin does a timeline on the evidence against Dr. Fauci et al.

Reiner Fuellmich and his German Corona Investigative Committee interview Dr. David Martin. 

In this interview, Dr. Martin goes into detail about how the patents for SARS Coronavirus existed before any "outbreaks." as did the patents on "spike proteins" to produce vaccine. They precede the current Covid-19 virus by 20 years.

The original research into these vaccines was for veterinary purposes, rabbits and canines, and then was used in 2002 and later by Anthony Fauci and the U.S. National Institute of Health for AIDS vaccine research. DARPA the got involved for applications as a "bioweapon."

When Anthony Fauci originally tried to get a patent on a mRNA vaccine for HIV, he was rejected by the patent office because his mRNA vaccine did not meed the legal definition of a 'vaccine." It is a biological weapon.

Dr. David Martin: "This comes directly from a patent application filed on April 19th, 2002 where the NIAID built an infectious replication defective coronavirus that was specifically targeted for human lung epithelium. In other words, we made SARS and we patented it on April 19th, 2002 before there was ever any alleged outbreak in Asia which as you know follow that by several months. That patent issued as US Patent #7279327. That patent clearly lays out in very specific gene sequencing, the fact we knew the ACE receptor, the ACE2 binding domain, the S1 spike protein and other elements in what we have come know as this scourge pathogen was not only engineered, but could be synthetically modified in the laboratory, using nothing more than gene sequencing technologies, taking computer code and turning it into a pathogen or an intermediate of the pathogen. And that technology was funded exclusively in the early days as a means by which we could actually harness Coronavirus as a vector to distribute HIV vaccine."

"The statement made by Dr. Peter Daszak in 2015 and was reported in the National Academies, a press publication on February 12th, 2016, 'We need to increase public understanding of the need for medical countermeasures, such as a pan Coronavirus vaccine. A key driver is the media and the economics will follow the hype. We need to use that hype to our advantage to get to the real issues. Investors will respond if they see profit at the end of the process.'"

"On the single patent required to develop the vaccine research Institute's mandate, which was shared between the University of North Carolina Chapel Hill in November of 2019 and Moderna November of 2019, when UNC Chapel Hill, NIAID and Moderna began the sequencing of a spike protein vaccine a month before an outbreak every happened.